Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FV1V4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,664
Award facts
- Contract value 100% obligated
- $11,663.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, valued at $11,663.99. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction under open competition. The order is scheduled for completion by August 13, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company's comprehensive IDC vehicle enables it to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. Through this prime vendor arrangement, AmerisourceBergen serves multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's extensive capability to fulfill complex federal medical supply requirements across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FV1V4?
SPE2DB25FV1V4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FV1V4 worth?
The government has obligated $11,664 on SPE2DB25FV1V4.
Is contract SPE2DB25FV1V4 an order under another contract?
Yes. SPE2DB25FV1V4 is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FV1V4 competed?
The extent of competition for SPE2DB25FV1V4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award